Approval · Notice of Compliance 14213 · 2013
CERETEC: Notice of Compliance 14213
Issued March 13, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14213
- Date
- March 13, 2013
- Company
- Ge Healthcare Canada IncMississauga, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing facility
- Therapeutic class
- Radiopharmaceutical diagnostic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CERETEC | Not yet assigned | — |
Medicinal ingredients
- EXAMETAZIME 0.5 MG per VIAL